Zobrazeno 1 - 6
of 6
pro vyhledávání: '"14(3)"'
Autor:
Kathleen T. McKie, Gareth W. Davison, Nichole Seigler, Ryan A. Harris, Jeremy Fielding, Lucy Brantley
Publikováno v:
Pediatric Pulmonology. 50:647-654
SUMMARY Exercise capacity, an objective measure of exercise intolerance, is known to predict quality of life and mortality in cystic fibrosis (CF). The mechanisms for exercise intolerance in patients with cystic fibrosis (CF), however, have yet to be
Autor:
Hitomi Shinohara, Hideya Kodama
Publikováno v:
Pediatrics International. 53:29-35
Background: There have been calls for more aggressive intervention for infants with failure in development of a sleep–wake rhythm. If development of the ‘biological clock’ in infants can be assessed by measuring melatonin, this may provide a us
Autor:
Carmen D'Ugard, Nelson Claure, Yoshirou Wada, Eduardo Bancalari, Ximena Alegria, Cristian Esquer
Publikováno v:
Pediatric Pulmonology. 41:759-764
Background Positive end expiratory pressure (PEEP) is routinely used in mechanically ventilated preterm infants to maintain lung volume. An acute increase in PEEP can affect lung mechanics and tidal volume, but it is unknown if these effects elicit c
Publikováno v:
Acta Paediatrica. 90:1456-1463
UNLABELLED The course and psychological correlates of disturbed sleep during middle childhood were investigated using parents' responses to questionnaires. Five specified sleep disturbances were explored in 614 5-8-y-old children, at baseline and at
Publikováno v:
Paediatric and Perinatal Epidemiology, 14, 268-274
Paediatric and Perinatal Epidemiology, 14, 3, pp. 268-274
Paediatric and Perinatal Epidemiology, 14, 3, pp. 268-274
The objective of this population-based cohort study was to evaluate the prevalence of persistent otitis media with effusion (OME) and its seasonal variation in 12-month-old infants. All 30099 infants born in the eastern part of The Netherlands betwee
Publikováno v:
Pediatric Pulmonology. 27:383-387
The purpose of this study was to compare the effects of daily inhaled beclomethasone (3 x 500 microg) started on day 3 of life, with that of systemic dexamethasone (0.5 mg/kg/day) started between days 11-13 on clinical variables, lung inflammation, a